DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $197,741 | +6.4% | 13,388 | -7.0% | 0.07% | +10.0% |
| Q2 2023 | $185,893 | -9.7% | 14,388 | -31.4% | 0.06% | -63.0% |
| Q1 2023 | $205,892 | +21.0% | 20,988 | +31.3% | 0.16% | +45.9% |
| Q4 2022 | $170,112 | -11.9% | 15,988 | -13.5% | 0.11% | -2.6% |
| Q3 2022 | $193,000 | -4.5% | 18,488 | +15.5% | 0.11% | -38.7% |
| Q2 2022 | $202,000 | +14.1% | 16,009 | -1.8% | 0.19% | +27.4% |
| Q1 2022 | $177,000 | +78.8% | 16,300 | +63.0% | 0.15% | +403.4% |
| Q2 2021 | $99,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |